|
1.
|
Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial. MedStar authors:
Year: 2015
Citation: - Circulation: Cardiovascular Interventions. 8(2):e001441, 2015 Feb.
Institution: - MedStar Heart & Vascular Institute
All authors: - Barragan P, Bilger J, Cook S, Erne P, Goicolea J, Haude M, Juni P, Lefevre T, Merkely B, Neumann FJ, Piot C, Richardt G, Sabate M, Schneider H, Slagboom T, Stangl K, Waksman R, Windecker S, Witzenbichler B, Zaugg S
|
|
2.
|
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent. MedStar authors:
Year: 2013
Citation: - Eurointervention. 9(3):308-15, 2013 Jul.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Allocco DJ, Banning A, Barragan P, Dawkins KD, Kelbaek H, Kubica J, Masotti M, Meredith IT, Scott D, Sjogren I, Stables RH, Thuesen L, Valdes Chavarri M, Verheye S, Walters DL, Weissman NJ, West NE, Whitbourn R
|